×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 6: The IND in Detail - Modules 4 and 5
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- IND Item: Nonclinical Pharmacology and Toxicology
- IND Item: Previous Human Experience
- IND Item: Additional Information
Have an account?